Determining urinary trace elements (Cu, Zn, Pb, As, and Se) in patients with bladder cancer

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 3, 2009, Pages 192-195

  Lin, Chang Ni ^a   Wang, Lai Hao ^a   Shen, Kun Hung ^b  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Invasive bladder cancer; Superficial bladder cancer; Trace elements

Indexed keywords

ARSENIC; COPPER; LEAD; SELENIUM; ZINC;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLADDER CANCER; CANCER RISK; CHINESE HERB; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; SEX DIFFERENCE; URINALYSIS; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ARSENIC; COPPER; FEMALE; HUMANS; LEAD; MALE; MIDDLE AGED; NEOPLASM STAGING; SELENIUM; SEX CHARACTERISTICS; TAIWAN; TRACE ELEMENTS; URINARY BLADDER NEOPLASMS; ZINC;

EID: 66349107679     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20318     Document Type: Article

References (34)

1. Daniel KG, Harbach RH, Guida WC, Dou QP. Copper storage diseases: Menkes, Wilson's and cancer. Front Biosci 2004;9:2652-2662.
2. Janet YUA, Carl LK. Copper, oxidative stress, and human health. Mol Aspects Med 2005;26:268-298.
3. Yaman M, Atici D, Bakirdere S, Akdeniz I. Comparison of trace metal concentrations in malign and benign human prostate. J Med Chem 2005;48:630-634. (Pubitemid 40139805)
4. Fukuda H, Ebara M, Yamada H, et al. Trace elements and cancer. J Jpn Med Assoc 2004;47:391-395.
5. Malone WF, Kelloff GJ, Pierson H, Greenwald P. Chemoprevention of bladder cancer. Cancer 1987;60:650-657. (Pubitemid 17103141)
6. Eilic E, Demiroglu A, Saraymen R, Ok E. Comparative quantitative analysis of zinc, magnesium, and copper content in the scalp hair of healthy people and breast cancer patients. J Trace Elem Exp Med 2004;17:175-180. (Pubitemid 38982211)
7. Gupta SK, Singh SP, Shukla VK. Copper, zinc, and Cu/Zn ratio in carcinoma of the gallbladder. J Surg Oncol 2005;91:204-208. (Pubitemid 41254425)
8. Johnson AR, Munoz A, Gottlieb JL, Jarrard DF. High dose zinc increases hospital admissions due to genitourinary complications. J Urol 2007;177:639-643. (Pubitemid 46054024)
9. Kovala-Demertzi D, Yadav PN, Wiecek J, Skoulika S, Varadinova T, Demertzis MA. Zinc(II) complexes derived from pyridine-2-carbaldehyde thiosemicarbazone and (1E)-1-pyridin-2- ylethan-1-one thiosemicarbazone. Synthesis, crystal structures and antiproliferative activity of zinc(II) complexes. J Inorg Biochem 2006;100:1558-1567. (Pubitemid 44209187)
10. Feustel A, Wennrich R, Dittrich H. Zinc, cadmium and selenium concentrations in separated epithelium and stroma from prostatic tissues of different histology. Urol Res 1987;15:161-163. (Pubitemid 17116902)
11. Margalioth EJ, Schenker JG, Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer 1983;52:868-872.
12. Goyal MM, Kalwar AK, Vyas RK, Bhati A. A study of serum zinc, selenium and copper levels in carcinoma of esophagus patients. Indian J Clin Biochem 2006;21:208-210.
13. Torun M, Aldemir H, Yardim S. Serum selenium levels in various cancer types. Trace Elem Electrolytes 1995;12:186-190.
14. Luty-Frackiewicz A. The role of selenium in cancer and viral infection prevention. Int J Occup Med Environ Health 2005;18:305-311. (Pubitemid 43189594)
15. Brinkman M, Buntinx F, Muls E, Zeegers MP. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol 2006;7:766-774. (Pubitemid 44283670)
16. Diwadkar-Navsariwala V, Diamond AM. The link between selenium and chemoprevention: A case for selenoproteins. J Nutr 2004;134:2899-2902. (Pubitemid 39470058)
17. Kellen E, Zeegers M, Buntinx F. Selenium is inversely associated with bladder cancer risk: A report from the Belgian case-control study on bladder cancer, Inter. J Urol 2006;13:1180-1184. (Pubitemid 44410906)
18. Michaud DS, Hartman TJ, Taylor PR, et al. No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1505-1506. (Pubitemid 35340395)
19. Tsai JL, Hwang TJ, Horng PH, Hsu JW, Horng CJ. Determination of urinary trace elements (arsenic, copper, cadmium, manganese, lead, zinc, selenium) in patients with Blackfoot disease. Arch Environ Health 2004;59:686-692. (Pubitemid 43926021)
20. Horng CJ, Lin SR. Determination of urinary trace elements (As, Hg, Zn, Pb, Se) in patients with Blackfoot disease. Talanta 1997;45:75-83. (Pubitemid 27506698)
21. World Health Organization. Water Sanitation and Health (WSH). Water-related diseases. Arsenicosis. 2001. Available at: www.who.int/water- sanitation-health/diseases/arsenicosis/en (Accessed on 18 December 2008).
22. Hour TC, Huang CY, Lin CC, et al. Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide. Anticancer Drugs 2004;15:779-785. (Pubitemid 39281302)
23. Kaplan LA, Pesce AJ. Clinical Chemistry: Theory, Analysis, Correlation, third edition. St. Louis, MO: Mosby Year Book Inc. 1996. p 746-757.
24. Burtis CA, Ashwood ER, editors. Tietz Fundamentals of Clinical Chemistry, fourth edition. Philadelphia, PA: WB Saunders Co. 1996. p 485-496.
25. Fraga CG. Relevance, essentiality and toxicity of trace elements in human health. Mol Aspects Med 2005;26:235-244. (Pubitemid 41225351)
26. Oteiza PI, Mackenzie GG. Zinc, oxidant-triggered cell signaling, and human health. Mol Aspects Med 2005;26:245-255. (Pubitemid 41226495)
27. Kvirikadze NA. Content of trace elements in the urine of patients with bladder tumors. Soobshcheniya Akad Nauk Gruzinskoi SSR 1967;45:241-245.
28. Malczyk E, Darewicz B, Pawlak D, Darewicz J, Buczko W. Investigations of urinary lead concentration in patients with urinary bladder carcinoma. Int Urol Nephrol 1999;31:661-663. (Pubitemid 30179122)
29. Irmak S, Tilki D, Heukeshoven J, et al. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer. Proteomics 5:4296-4304.
30. Daniel KG, Harbach RH, Guida WC, Dou QP. Copper storage diseases: Menkes, Wilson's, and cancer. Front Biosci 2004;9:2652-2662.
31. Kvirikadze NA. Chemical form of Mn, Pb, Cu, Ag, Zn, Ti, and Ni in malignant tumors of urinary bladder. Soobshcheniya Akad Nauk Gruzinskoi SSR 1964;35:579-586.
32. Witkowska AM, Darewicz B, Markiewicz R, Borawska MH, Hukalowicz K. 2002. Soluble cell adhesion molecule-1, selenium and diet in renal and urinary bladder cancers. In: Metal ions in biology and medicine (Les ions métalliques en biologie Et en médecine. By Russie Symposium international sur les ions métalliques en biologie et en médecine 07 Saint-Petersbourg, Lylia Khassanova, Ivan Maymard, Jean-Claude Étienne, Philippe Collery. Montrouge, France: John Libbey Eurotext, XIII Oncology. p 595-599.
33. Kondo N, Ota N, Nakai I, Sasaki A. Synchrotron radiation-induced total-reflection X-ray fluorescence analysis of Cu and Zn in carcinoma tissues obtained by a biopsy. Bunseki Kagaku 1997;46:957-964. (Pubitemid 128026081)
34. Borawska MH, Markiewicz R, Hukalowicz K, Witkowska AM, Czyzewska E. Serum zinc concentrations in certain diseases. Met Ions Biol Med 2004;8:428-431.